共 50 条
- [21] A case of JAK2V617F-positive essential thrombocythemia where allele burden was reduced by a PD-1 inhibitor International Journal of Hematology, 2021, 113 : 606 - 610
- [22] IMPACT OF JAK2 V617F MUTATION ON CLINICAL OUTCOME OF PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA: A RETROSPECTIVE STUDY HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 507 - 507
- [23] Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera Annals of Hematology, 2015, 94 : 717 - 719
- [25] Chronic urticaria reveals JAK2V617F positive essential thrombocythemia POSTEPY DERMATOLOGII I ALERGOLOGII, 2022, 39 (03): : 642 - 644
- [26] JAK2V617F mutation in Korean patients with essential thrombocythemia KOREAN JOURNAL OF LABORATORY MEDICINE, 2007, 27 (02): : 77 - 82
- [28] Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2007, 191 (03): : 535 - 548
- [29] Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS) International Journal of Hematology, 2015, 101 : 405 - 410